Literature DB >> 26400851

Ottawa Panel evidence-based clinical practice guidelines for therapeutic exercise in the management of hip osteoarthritis.

Lucie Brosseau1, George A Wells2, Arlanna G Pugh3, Christine Am Smith2, Prinon Rahman4, Inmaculada C Àlvarez Gallardo5, Karine Toupin-April6, Laurianne Loew7, Gino De Angelis2, Sabrina Cavallo8, Jade Taki9, Rachel Marcotte10, Marlene Fransen11, Gabriela Hernandez-Molina12, Glen P Kenny10, Jean-Philippe Regnaux13, Marie-Martine Lefevre-Colau14, Sydney Brooks15, Lucie Laferriere16, Linda McLean7, Guy Longchamp17.   

Abstract

OBJECTIVES: The primary objective is to identify effective land-based therapeutic exercise interventions and provide evidence-based recommendations for managing hip osteoarthritis. A secondary objective is to develop an Ottawa Panel evidence-based clinical practice guideline for hip osteoarthritis.
METHODS: The search strategy and modified selection criteria from a Cochrane review were used. Studies included hip osteoarthritis patients in comparative controlled trials with therapeutic exercise interventions. An Expert Panel arrived at a Delphi survey consensus to endorse the recommendations. The Ottawa Panel hierarchical alphabetical grading system (A, B, C+, C, D, D+, or D-) considered the study design (level I: randomized controlled trial and level II: controlled clinical trial), statistical significance (p < 0.5), and clinical importance (⩾15% improvement).
RESULTS: Four high-quality studies were included, which demonstrated that variations of strength training, stretching, and flexibility exercises are generally effective for improving the management of hip osteoarthritis. Strength training exercises displayed the greatest improvements for pain (Grade A), disability (Grades A and C+), physical function (Grade A), stiffness (Grade A), and range of motion (Grade A) within a short time period (8-24 weeks). Stretching also greatly improved physical function (Grade A), and flexibility exercises improved pain (Grade A), range of motion (Grade A), physical function (Grade A), and stiffness (Grade C+).
CONCLUSION: The Ottawa Panel recommends land-based therapeutic exercise, notably strength training, for management of hip osteoarthritis in reducing pain, stiffness and self-reported disability, and improving physical function and range of motion.
© The Author(s) 2015.

Entities:  

Keywords:  Therapeutic exercise; evidence-based clinical practice guideline; management; osteoarthritis; recommendations; rehabilitation; rheumatology; systematic review

Mesh:

Year:  2015        PMID: 26400851     DOI: 10.1177/0269215515606198

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  14 in total

1.  Translation of Fit & Strong! for Use by Hispanics With Arthritis: A Feasibility Trial of ¡En Forma y Fuerte!

Authors:  Cheryl Der Ananian; Renae Smith-Ray; Brad Meacham; Amy Shah; Susan Hughes
Journal:  J Aging Phys Act       Date:  2017-09-22       Impact factor: 1.961

2.  Comparison between exercise therapy and non-hydrolyzed collagen (UC-II) in functionality and quality of life in women with knee osteoarthritis : A randomized controlled clinical trial.

Authors:  Érika Thatyana Nascimento Santana; Saulo da Cunha Machado; Viviane Nascimento Brandão Lima; Valter Joviniano DeSantana Filho; Leonardo Yung Dos Santos Maciel; Jader Pereira de Farias Neto; Henrique Douglas Melo Coutinho; Natália Martins; Walderi Monteiro da Silva Júnior; Lucindo J Quintans Júnior
Journal:  Wien Klin Wochenschr       Date:  2022-05-25       Impact factor: 1.704

3.  A diagnosis of knee osteoarthritis does not predict physical activity 2 years later in older adults: findings from the Hertfordshire Cohort Study.

Authors:  Michael A Clynes; Camille Parsons; Mark H Edwards; Jonathan H Tobias; Kevin Deere; Cyrus Cooper; Elaine M Dennison
Journal:  Rheumatol Int       Date:  2019-04-29       Impact factor: 2.631

4.  Targeted gluteal exercise versus sham exercise on self-reported physical function for people with hip osteoarthritis (the GHOst trial - Gluteal exercise for Hip Osteoarthritis): a protocol for a randomised clinical trial.

Authors:  Adam Ivan Semciw; Tania Pizzari; Stephanie Woodley; Anita Zacharias; Michael Kingsley; Rod A Green
Journal:  Trials       Date:  2018-09-20       Impact factor: 2.279

5.  Evaluation of a guideline developed to reduce HIV-related stigma and discrimination in healthcare settings and establishing consensus.

Authors:  Garumma Tolu Feyissa; Craig Lockwood; Mirkuzie Woldie; Zachary Munn
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

6.  Individuals with mild-to-moderate hip osteoarthritis have lower limb muscle strength and volume deficits.

Authors:  Aderson Loureiro; Maria Constantinou; Laura E Diamond; Belinda Beck; Rod Barrett
Journal:  BMC Musculoskelet Disord       Date:  2018-08-21       Impact factor: 2.362

7.  Can the Pain Attitudes and Beliefs Scales be adapted for use in the context of osteoarthritis with general practitioners and physiotherapists?

Authors:  Daniel W O'Brien; Sandra Bassett; Valerie Wright-St Clair; Richard J Siegert
Journal:  BMC Rheumatol       Date:  2020-04-10

Review 8.  Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2018-11-02

9.  Better before-better after: efficacy of prehabilitation for older patients with osteoarthritis awaiting total hip replacement-a study protocol for a randomised controlled trial in South-Eastern Norway.

Authors:  Odd-Einar Svinøy; Astrid Bergland; May Arna Risberg; Are Hugo Pripp; Gunvor Hilde
Journal:  BMJ Open       Date:  2019-12-30       Impact factor: 2.692

10.  The feasibility and effectiveness of internet-based rehabilitation for patients with knee osteoarthritis: A study protocol of randomized controlled trial in the community setting.

Authors:  Su-Hang Xie; Qian Wang; Li-Qiong Wang; Si-Yi Zhu; Yi Li; Cheng-Qi He
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.